Peptide-Based RDC Design to Achieve Target Molecule & Dosimetry Profile

• Investigating strategies to design peptide-based radiopharmaceuticals that precisely bind desired molecular targets for improved therapeutic efficacy
• Understanding methods to predict and modulate radiation distribution, minimizing off-target exposure and enhancing safety
• Gaining insights into integrating design, preclinical evaluation, and dosimetry planning to streamline progression from concept to clinical application

New Company for 2026

Speakers:

Keene Wei

Chief Executive Officer

Vitsgen